International Journal of Cancer Management

Published by: Kowsar

Molecular Detection and Typing of Human Papillomaviruses in Paraffin-Embedded Cervical Cancer and Pre-Cancer Tissue Specimens

Pezhman Mahmoodi 1 , * , Hossein Motamedi 2 , Masoud Reza Seyfi Abad Shapouri 3 , Mahjabin Bahrami Shehni 4 and Mohammad Kargar 4
Authors Information
1 Department of Pathobiology, Faculty of Para Veterinary Science, Bu-Ali Sina University, Hamadan, IR Iran
2 Department of Biology, Faculty of Science, Shahid Chamran University, Ahvaz, IR Iran
3 Department of Pathobiology, Faculty of Veterinary Medicine, Shahid Chamran University, Ahvaz, IR Iran
4 Department of Microbiology, Jahrom Branch, Islamic Azad University, Jahrom, IR Iran
Article information
  • Iranian Journal of Cancer Prevention: February 28, 2016, 9 (1); e3752
  • Published Online: February 22, 2016
  • Article Type: Research Article
  • Received: August 4, 2015
  • Revised: September 11, 2015
  • Accepted: January 17, 2016
  • DOI: 10.17795/ijcp-3752

To Cite: Mahmoodi P, Motamedi H, Seyfi Abad Shapouri M R, Bahrami Shehni M, Kargar M. Molecular Detection and Typing of Human Papillomaviruses in Paraffin-Embedded Cervical Cancer and Pre-Cancer Tissue Specimens, Int J Cancer Manag. 2016 ; 9(1):e3752. doi: 10.17795/ijcp-3752.

Copyright © 2016, Iranian Journal of Cancer Prevention.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Bruni L, Barrionuevo-Rosas L, Serrano B, Brotons M, Cosano R, Mu-oz J. Human Papillomavirus and Related Diseases in World (Summary Report ): 2014;
  • 2. Ngelangel C, Munoz N, Bosch FX, Limson GM, Festin MR, Deacon J, et al. Causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst. 1998; 90(1): 43-9[PubMed]
  • 3. Roteli-Martins CM, Panetta K, Alves VA, Siqueira SA, Syrjanen KJ, Derchain SF. Cigarette smoking and high-risk HPV DNA as predisposing factors for high-grade cervical intraepithelial neoplasia (CIN) in young Brazilian women. Acta Obstet Gynecol Scand. 1998; 77(6): 678-82[PubMed]
  • 4. Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer. 1995; 76(10 Suppl): 1888-901[PubMed]
  • 5. Acladious NN, Sutton C, Mandal D, Hopkins R, Zaklama M, Kitchener H. Persistent human papillomavirus infection and smoking increase risk of failure of treatment of cervical intraepithelial neoplasia (CIN). Int J Cancer. 2002; 98(3): 435-9[PubMed]
  • 6. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995; 87(11): 796-802[PubMed]
  • 7. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999; 189(1): 12-9[DOI][PubMed]
  • 8. Bosch FX, Munoz N. The viral etiology of cervical cancer. Virus Res. 2002; 89(2): 183-90[PubMed]
  • 9. Crawford LV, Crawford EM. A Comparative Study of Polyoma and Papilloma Viruses. Virology. 1963; 21: 258-63[PubMed]
  • 10. Park TW, Fujiwara H, Wright TC. Molecular biology of cervical cancer and its precursors. Cancer. 1995; 76(10 Suppl): 1902-13[PubMed]
  • 11. Southern SA, Herrington CS. Disruption of cell cycle control by human papillomaviruses with special reference to cervical carcinoma. Int J Gynecol Cancer. 2000; 10(4): 263-74[PubMed]
  • 12. Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology. 2010; 401(1): 70-9[DOI][PubMed]
  • 13. zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology. 1991; 184(1): 9-13[PubMed]
  • 14. zur Hausen H. Papillomavirus infections--a major cause of human cancers. Biochim Biophys Acta. 1996; 1288(2)-78[PubMed]
  • 15. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003; 16(1): 1-17[PubMed]
  • 16. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003; 348(6): 518-27[DOI][PubMed]
  • 17. Villa LL, Denny L. CHAPTER 7 Methods for detection of HPV infection and its clinical utility. Int J Gynecol Obstet. 2006; 94-80[DOI]
  • 18. Abreu AL, Souza RP, Gimenes F, Consolaro ME. A review of methods for detect human Papillomavirus infection. Virol J. 2012; 9: 262[DOI][PubMed]
  • 19. Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ, Chimera J, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA. 1991; 265(4): 472-7[PubMed]
  • 20. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007; 121(3): 621-32[DOI][PubMed]
  • 21. Shi SR, Cote RJ, Wu L, Liu C, Datar R, Shi Y, et al. DNA extraction from archival formalin-fixed, paraffin-embedded tissue sections based on the antigen retrieval principle: heating under the influence of pH. J Histochem Cytochem. 2002; 50(8): 1005-11[PubMed]
  • 22. Naqvi SH, Wajid S, Mitra AB. Restriction fragment length polymorphism of L1 amplicon using Rsa 1 detects five different human papillomavirus types and their co-infections among women attending a gynaecological outpatient department. J Virol Methods. 2004; 117(1): 91-5[DOI][PubMed]
  • 23. Announcement of the Society of Gynecologic Oncologists, Statement on a Cervix Cancer Vaccine. Gynecol Oncol. 2006; 101(3): 377[DOI]
  • 24. Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA. 2002; 288(14): 1749-57[PubMed]
  • 25. Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet. 2004; 364(9447): 1757-65[DOI][PubMed]
  • 26. Villa LL, Ault KA, Giuliano AR, Costa RL, Petta CA, Andrade RP, et al. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. Vaccine. 2006; 24(27-28): 5571-83[DOI][PubMed]
  • 27. Paavonen J, Jenkins D, Bosch FX, Naud P, Salmeron J, Wheeler CM, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet. 2007; 369(9580): 2161-70[DOI][PubMed]
  • 28. Sadeghi A, Sobhani A, Etaati Z, Jahanlu A, Shiroodi M. Prevalence of human papilloma virus among women with cervical intraepithelial neoplasia III and invasive cervical cancer from 2001 to 2006 in Bandarabas. Iranian J Pathol. 2008; 3(4): 183-5
  • 29. Maleknejad P, Rakhshan M, Kazemi B, Farokh F, Shahsava S. Detection of human papilomavirus types 16 and 18 in pathologic samples from patients with cervical cancer by PCR and RFLP methods. Daru J Pharmaceut Sci. 2006; 14(2): 78-81
  • 30. Han CH, Cho HJ, Lee SJ, Bae JH, Bae SN, Namkoong SE, et al. The increasing frequency of cervical cancer in Korean women under 35. Cancer Res Treat. 2008; 40(1): 1-5[DOI][PubMed]
  • 31. Yang YY, Koh LW, Tsai JH, Tsai CH, Wong EF, Lin SJ, et al. Correlation of viral factors with cervical cancer in Taiwan. J Microbiol Immunol Infect. 2004; 37(5): 282-7[PubMed]
  • 32. Schellekens MC, Dijkman A, Aziz MF, Siregar B, Cornain S, Kolkman-Uljee S, et al. Prevalence of single and multiple HPV types in cervical carcinomas in Jakarta, Indonesia. Gynecol Oncol. 2004; 93(1): 49-53[DOI][PubMed]
  • 33. Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, Klein RS, et al. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol. 1997; 35(6): 1304-10[PubMed]
  • 34. Venceslau EM, Bezerra MM, Lopes ACM, Souza ÉV, Onofre A, Melo C, et al. HPV detection using primers MY09/MY11 and GP5+/GP6+ in patients with cytologic and/or colposcopic changes. Jornal Brasileiro de Patologia e Medicina Laboratorial. 2014; 50(4)[DOI]
  • 35. Burk RD, Kelly P, Feldman J, Bromberg J, Vermund SH, DeHovitz JA, et al. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis. 1996; 23(4): 333-41[PubMed]
  • 36. Cuzick J, Singer A, De Stavola BL, Chomet J. Case-control study of risk factors for cervical intraepithelial neoplasia in young women. Eur J Cancer. 1990; 26(6): 684-90[PubMed]
  • 37. Louie KS, de Sanjose S, Diaz M, Castellsague X, Herrero R, Meijer CJ, et al. Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Br J Cancer. 2009; 100(7): 1191-7[DOI][PubMed]
  • 38. Kruger-Kjaer S, van den Brule AJ, Svare EI, Engholm G, Sherman ME, Poll PA, et al. Different risk factor patterns for high-grade and low-grade intraepithelial lesions on the cervix among HPV-positive and HPV-negative young women. Int J Cancer. 1998; 76(5): 613-9[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments